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Major depletion of SOX2+ stem 
cells in the adult pituitary is not 
restored which does not affect 
hormonal cell homeostasis and 
remodelling
Heleen Roose1, Benoit Cox1, Matteo Boretto1, Conny Gysemans2, Annelies Vennekens1 & 
Hugo Vankelecom1
The pituitary gland contains SOX2-expressing stem cells. However, their functional significance remains 
largely unmapped. We investigated their importance by depleting SOX2+ cells through diphtheria toxin 
(DT)-mediated ablation. DT treatment of adult Sox2CreERT2/+;R26iDTR/+ mice (after tamoxifen-induced 
expression of DT receptor in SOX2+ cells) resulted in 80% obliteration of SOX2+ cells in the endocrine 
pituitary, coinciding with reduced pituisphere-forming activity. Counterintuitively for a stem cell 
population, the SOX2+ cell compartment did not repopulate. Considering the more active phenotype 
of the stem cells during early-postnatal pituitary maturation, SOX2+ cell ablation was also performed 
in 4- and 1-week-old animals. Ablation grade diminished with decreasing age and was accompanied 
by a proliferative reaction of the SOX2+ cells, suggesting a rescue attempt. Despite this activation, 
SOX2+ cells did also not recover. Finally, the major SOX2+ cell depletion in adult mice did not affect 
the homeostatic maintenance of pituitary hormonal cell populations, nor the corticotrope remodelling 
response to adrenalectomy challenge. Taken together, our study shows that pituitary SOX2+ fail 
to regenerate after major depletion which does not affect adult endocrine cell homeostasis and 
remodelling. Thus, pituitary SOX2+ cells may constitute a copious stem cell reserve or may have other 
critical role(s) still to be clearly defined.
The pituitary gland plays a pivotal role in the endocrine system and governs essential physiological processes 
like growth, metabolism, puberty, reproduction and stress response. The gland consists of different lobes, the 
anterior pituitary (AP), intermediate lobe (IL) and posterior pituitary. The AP represents the major endocrine 
part of the gland producing the key hormones prolactin (PRL), growth hormone (GH), adrenocorticotropic hor-
mone (ACTH), thyroid-stimulating hormone (TSH), luteinizing hormone (LH) and follicle-stimulating hormone 
(FSH). Because of its central role, malfunctioning of the pituitary has critical consequences for body physiology, 
causing, amongst others, diabetes, cardiovascular disease, osteoporosis, infertility and/or psychological disor-
ders1. Pituitary hormonal cell populations must therefore be maintained in a controlled and balanced manner.
Postnatal turnover of tissues classically includes the generation of new mature cells from resident stem cells. 
In the pituitary, stem cells have been identified, displaying as central characteristic the expression of the stemness 
regulator SRY-related HMG box transcription factor 2 (SOX2)2–5. Despite their identification about 10 years ago, 
the functional role of the stem cells in the postnatal gland is far from clear. Following pituitary damage as inflicted 
by transgenic endocrine cell ablation, the SOX2+ stem cell compartment becomes activated; acute expansion of 
the SOX2+ cell population and co-expression of the ablated hormone supports their involvement in the regener-
ative response that is unfolding upon injury6–8. Recent genetic lineage tracing studies revealed that SOX2+ cells 
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contribute to the different hormonal cell types during postnatal homeostatic turnover but only at low frequency, 
while displaying long-term persistence suggesting a long-lived character and (slow) self-renewal activity9,10. In 
addition, pituitary SOX2+ cells have been suggested to act as signalling centres, particularly in disease condi-
tions like tumorigenesis in which paracrine signalling from (activated) SOX2+ cells have the capacity to promote 
tumour development in the gland9,11. Here, we aimed at investigating the functional significance of SOX2+ cells 
in the postnatal pituitary by ablating these cells using a transgenic diphtheria toxin (DT)-mediated system. In 
addition, we explored the self-regenerating capacity of the SOX2+ pituitary stem cells. Our study shows that 
SOX2+ cells of the adult pituitary do not restore their own cell compartment after major depletion, which does 
not affect the maintenance of the different hormonal cell populations during homeostasis, nor the endocrine cell 
remodelling as triggered by adrenalectomy.
Results
SOX2+ cells do not repopulate after major ablation in the adult pituitary. To investigate the role 
of the SOX2+ cells in the adult pituitary, we embarked on their ablation by using the DT/inducible DT receptor 
(iDTR) system. The iDTR mouse was crossed to the SOX2CreERT2 mouse in which CreERT2 is expressed under 
control of the endogenous Sox2 promoter and activated by tamoxifen (TAM). Mice were treated with TAM and 
DT according to an optimized schedule (see Methods and Fig. 1a).
The pituitary of TAM/DT-injected adult (8- to 12-week-old) Sox2CreERT2/+;R26iDTR/+ mice (further referred 
to as ‘Sox2/iDTR’), as isolated immediately after DT treatment (i.e. at d9; see Fig. 1a), did morphologically not 
differ from the glands of control Sox2+/+;R26iDTR/+ littermates (further referred to as ‘-/iDTR’) (Supplementary 
Fig. S1). However, immunofluorescence examination of pituitary sections showed a clear loss in SOX2+ cells 
when compared to controls, both in male and female mice (Fig. 1b; Supplementary Fig. S2). The DT treatment 
induced cell apoptosis in the SOX2+ cells as shown by cleaved caspase 3 (CC3) immunostaining (Supplementary 
Fig. S2). Especially the SOX2+ cells in the marginal-zone (MZ) stem cell niche (i.e. around the cleft which is the 
remnant lumen of the embryonic pituitary) were found to be eliminated, coinciding with a major decrease in MZ 
cells expressing E-cadherin and SOX9, two other pituitary stem cell markers2,9,10,12 (Supplementary Fig. S2). In 
accordance, gene expression levels in the AP of these markers (and another pituitary stem cell marker as found 
in rat, Cxadr or coxsackie virus and adenovirus receptor13) were reduced (Supplementary Fig. S2). Within the 
AP parenchyma, SOX2+ cells were still observed. The remaining parenchymal SOX2+ cells often represented 
cells with SOX2-immunoreactive signal in the cytoplasm, not in the nucleus (Fig. 1b; Supplementary Fig. S2). 
Quantification using AP cell cytospin samples (pooled from male and female mice, see Methods) indeed con-
firmed that the cells with SOX2+ signal in the nucleus (further abbreviated as nSOX2+ cells) showed a major drop 
of ∼80% in the Sox2/iDTR mice (Fig. 1c), whereas the cells with SOX2+ signal in the cytoplasm (cSOX2+ cells) 
were not significantly affected (Supplementary Fig. S2). Absence of further active transcription of the Sox2 gene 
in these cSOX2+ cells may explain their escape from Sox2 promoter-driven ablation. In line with this hypothesis, 
CRE expression (as driven by the endogenous Sox2 promoter and translocated to the nucleus by TAM) was pre-
dominantly found in the cells with SOX2+ signal in the nucleus (Supplementary Fig. S2). In agreement with the 
drop in the nSOX2+ stem cells, stem cell-linked sphere-inducing capacity within the AP cell population was also 
strongly reduced (Fig. 1c). Multipotent differentiation capacity of the remaining sphere-inducing cells toward 
hormonal cells was still functional as tested for distinct hormonal cell lineages (i.e. ACTH+, GH+, PRL+ and 
αGSU+ cells, the latter encompassing the TSH+ thyrotropes and the LH+/FSH+ gonadotropes; Fig. 1d). Of note, 
the Sox2 hemizygous genotype as occurring in the Sox2/iDTR mouse (i.e. knock-in of the CreERT2 transgene in 
one Sox2 allele resulting in Sox2 haploinsufficiency) did not in itself affect the number of SOX2+ cells in the AP 
(Supplementary Fig. S3).
Next, we examined whether the SOX2+ cell compartment repopulated after its major depletion and therefore 
determined SOX2+ cell proportions 2, 4 and 6 months after ending the DT treatment (Fig. 2a). Intriguingly, the 
nSOX2+ stem cell population did not restore (Fig. 2b,c; ablation after 6 months versus d9: non-significant, see 
Supplementary Table S1), while the cSOX2+ cell proportion did not significantly change at all time points ana-
lysed when compared to control -/iDTR AP (Supplementary Fig. S2). Sphere-forming capacity also remained 
largely diminished after 6 months, while multipotent differentiation capacity of the lasting sphere-initiating cells 
was again not affected (Fig. 2d,e). Of note, the mice retained a healthy appearance during the whole 6-month 
period, in contrast to an earlier study in which lethality was observed after 2 weeks of continuously destroying 
the (dividing) SOX2+ cells with the thymidine kinase (TK)/ganciclovir (GCV) system, reportedly caused by dis-
rupted epithelial integrity and ulcer development in the stomach4. However, when GCV treatment was stopped 
once animals became morbid (i.e. after 1 week), gradual recovery was observed, coinciding with a repopulation 
of the SOX2+ cells in the stomach4. In our study, the TAM/DT treatment of Sox2/iDTR mice also caused an acute 
SOX2+ cell ablation in the stomach (as analysed at d9; Supplementary Fig. S4), but SOX2+ cell recovery was 
observed in this highly renewing tissue (as shown for the 6-month time point; Supplementary Fig. S4), most likely 
explaining the non-toxic impact on the animals.
Taken together, SOX2+ stem cells of the adult pituitary do not regenerate after major ablation, which is 
intriguing and counterintuitive for a stem cell population and which suggests that the adult pituitary stem cells do 
not need to restore to full number size for adequate basal pituitary functioning.
SOX2+ cells of the early-postnatal pituitary react to their ablation but also do not repopu-
late. During the neonatal and early-postnatal period, the mouse pituitary undergoes active growth and 
maturation with significant expansion of the hormonal cell populations14–16. We previously observed that the 
pituitary stem cell compartment is enlarged in the first weeks after birth and shows functional and molecular 
signs of activation16. In agreement, recent SOX2+ lineage tracing studies revealed a higher number of descend-
ant hormonal cells when tracing was initiated shortly after birth as compared to later in life9,10. Therefore, we 
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Figure 1. SOX2+ cell ablation in the pituitary of adult mice. (a) Time schedule of TAM/DT injections and 
pituitary analysis. (b) Pituitary vibratome sections isolated from adult, male and female control (-/iDTR) and 
Sox2/iDTR mice injected with TAM/DT and analysed for SOX2 (red) immediately after treatment (day 9, d9). 
Representative pictures are shown, the nucleus being labelled with TOPRO3 (blue). Scale bar: 50 μm. AP, 
anterior pituitary; IL, intermediate lobe. Surviving SOX2+ cells with immunoreactive signal in the cytoplasm 
(cSOX2+ cells) are indicated (arrows). (c) Percent decrease in nSOX2+ cells (SOX2+ signal in the nucleus) 
and in sphere-initiating (iSphere+) cells in the AP at d9 after TAM/DT injection of adult Sox2/iDTR mice as 
compared to -/iDTR control mice. Bars represent mean ± SEM (n = 4). *p < 0.05 (versus control). (d) Primary 
spheres at day 6 after seeding AP cells from adult Sox2/iDTR and -/iDTR control mice immediately after DT 
injection (d9). Primary (undifferentiated) spheres (day 6) were subjected to differentiation on Matrigel (for 
another 7 days) and immunostained before and after differentiation for SOX2 (red) and hormones (as indicated; 
green). Representative pictures are shown. Scale bar:  50 μm.
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Figure 2. SOX2+ cells do not repopulate after major ablation in the adult pituitary. (a) Time schedule of TAM/
DT injections and pituitary analysis. (b) Percent decrease in nSOX2+ cells in the AP after TAM/DT injection of 
adult Sox2/iDTR mice as compared to -/iDTR control mice at the different time points indicated. Bars represent 
mean (± SEM for n ≥ 3) (2 months: n = 1; 4 months: n = 2; 6 months: n = 4). (c) Pituitary vibratome sections 
isolated from adult control (-/iDTR) and Sox2/iDTR mice injected with TAM/DT and analysed for SOX2 (red) 
6 months after treatment. Representative pictures are shown, the nucleus being labelled with TOPRO3 (blue). 
Scale bar: 50 μm. cSOX2+ cells are indicated (arrows). (d) Percent decrease in iSphere+ cells 6 months after 
TAM/DT injection of adult Sox2/iDTR mice as compared to -/iDTR control mice. Bar represents mean ± SEM 
(n = 4). *p < 0.05 (versus control). (e) Primary spheres at day 6 after seeding AP cells from adult Sox2/iDTR 
and -/iDTR control mice 6 months after DT injection. Primary (undifferentiated) spheres were subjected to 
differentiation on Matrigel and immunostained before and after differentiation for SOX2 (red) and hormones 
(as indicated; green). Representative pictures are shown. Scale bar: 50 μm.
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Figure 3. SOX2+ cell ablation in the pituitary of early-postnatal mice: proliferative reaction but no 
regeneration. (a) Left: Cytospin samples of AP cells immunostained for SOX2 (red) from 4-week-old -/iDTR 
control and Sox2/iDTR mice immediately after DT treatment (d9) and 4 months later. Nuclei are labelled 
with DAPI (blue). Representative pictures are shown. Scale bar:  50 μm. Right: Bar graph showing the percent 
decrease (mean ± SEM; d9: n = 4; 4 months: n = 3) in nSOX2+ cells in the AP after TAM/DT injection of 
4-week-old Sox2/iDTR mice as compared to -/iDTR control mice at the different time points indicated. 
*p < 0.05 (versus control); NS, non-significant. (b) Percent ablation of nSOX2+ cells in the AP immediately 
(d9) after TAM/DT injection of Sox2/iDTR mice at different ages, as compared to -/iDTR control mice. Bars 
represent mean ± SEM (1-week old: n = 3; 4-week-old: n = 4; adult or 8–12 weeks old: n = 4). *p < 0.05. (c) 
Left: Percent decrease in nSOX2+ cells in the AP after TAM/DT injection of 1-week-old Sox2/iDTR mice as 
compared to -/iDTR control mice at the time points indicated. Bars represent mean ± SEM (n = 3). *p < 0.05 
(versus control). NS, non-significant. Right: Pituitary vibratome sections isolated from -/iDTR and Sox2/
iDTR mice injected at 1 week of age with TAM/DT and analysed for SOX2 (red) immediately after treatment 
(d9). Representative combined immunofluorescent/brightfield-contrast and immunfluorescent pictures are 
shown, the nucleus being labelled with TOPRO3 (blue). Scale bar: 50 μm. (d) Left: Pituitary vibratome sections 
isolated from -/iDTR and Sox2/iDTR mice injected at 1 week of age with TAM/DT and analysed for SOX2 (red) 
and Ki67 (green) at d7 (i.e. after the first day of DT injection, see Fig. 1a). Representative pictures are shown, 
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examined whether the more active pituitary SOX2+ stem cells as present in younger animals could recover after 
DT-mediated ablation.
First, we investigated 4-week-old mice and applied the TAM/DT injection schedule as described above. 
Analysis at d9 revealed a clear drop in pituitary nSOX2+ cells in the Sox2/iDTR mice (pooled male and female), 
however smaller than in adult mice (Fig. 3a,b). Again, cSOX2+ cells did not significantly change (Supplementary 
Fig. S5). Despite this smaller ablation grade as compared to adult mice, the number of nSOX2+ cells did also not 
restore as analysed 4 months later (Fig. 3a).
Then, we selected the earliest feasible time point of TAM/DT injection (meaning, without lethality), and 
treated 1-week-old pups (pooled male and female). Pituitary morphology did not visibly change (Supplementary 
Fig. S6). Ablation of nSOX2+ cells was observed, but again lower than in adults and also lower than in 4-week-old 
mice (Fig. 3b,c), while cSOX2+ cells did not significantly alter (Supplementary Fig. S6). DT-induced apoptosis 
was detected in the pituitary but not at high extent (as analysed at d7 and d9; Supplementary Fig. S6), which may 
suggest that the TAM/DT system shows low(-er) efficacy at this neonatal age, for instance because of less efficient 
delivery of the compounds in the very young animals and/or low expression of CRE (as indeed observed, see 
Supplementary Fig. S6). In addition, the more active SOX2+ stem cells of the neonatal pituitary may attempt to 
counteract their elimination. In line with this possibility, a clear increase in proliferating (Ki67+) nSOX2+ cells 
was observed in the Sox2/iDTR pituitary immediately after ablation when compared to control -/iDTR mice 
(Fig. 3d and Supplementary Fig. S6). Cycling SOX2+ cells particularly emerged in the MZ, which were prac-
tically not observed in the control pituitary. Moreover, Ki67 was only detected in the nSOX2+ cells and not in 
cSOX2+ cells (data not shown). A proliferative reaction of the nSOX2+ cells was also observed in the pituitary 
of 4-week-old mice (Supplementary Fig. S6), whereas proliferation within the SOX2+ cell compartment of adult 
pituitary did not change immediately after ablation, remaining almost undetectable as similar to control mice 
(data not shown). Nevertheless, despite the proliferative response of the nSOX2+ cells in the neonatal mice, their 
number was not restored when analysed 4–6 months later (Fig. 3c) at which time point virtually no proliferating 
nSOX2+ cells were observed anymore (Supplementary Fig. S6), in line with the static phenotype of the gland at 
adult age. cSOX2+ cells were again not different at 4–6 months (Supplementary Fig. S6).
Taken together, our data indicate that the SOX2+ stem cells in the young pituitary actively react to the destruc-
tion process within their compartment by acutely proliferating, plausibly to immediately restore their cell popu-
lation and/or to rescue the pituitary maturation process. Despite this reaction, the affected SOX2+ cell population 
did not repopulate, again suggesting that the stem cells do not need to restore to full number size for adequate 
basal pituitary functioning.
Proportions of hormonal cell populations do not change after SOX2+ cell ablation in the post-
natal pituitary. Turnover in adult tissues may involve several mechanisms, including the generation of new 
cells by the resident stem cells. Therefore, we addressed the question whether the major depletion of SOX2+ 
cells in the adult pituitary had an impact on the endocrine cell composition of the gland, either immediately 
after TAM/DT treatment (d9) or 4–6 months later. At both time points, the proportions of the different hor-
mone+ cell populations were not changed when compared to control -/iDTR pituitaries, independent of gender 
(Fig. 4a). Thus, absence of a major part of SOX2+ cells in the adult pituitary does not affect AP endocrine cell 
homeostasis. Other mechanisms may compensate to maintain the hormonal cell populations in the absence of 
SOX2+ cell-derived endocrine cell generation. First, other stem cell (sub-)populations, if present, may make up 
for the loss of the SOX2+ stem cell compartment. We analysed other pituitary stem cell markers and found that 
SOX9+ and E-cadherin+ cells were also not restored at 6 months after ablation, and that the gene expression lev-
els remained reduced (Supplementary Fig. S2). The formation of new endocrine cells may also be compensated 
for by higher proliferation and transdifferentiation of mature hormonal cells. We investigated these possibilities 
within the two largest hormonal cell populations, i.e. the GH+ and PRL+ lineages. Only few cells were double 
GH+/Ki67+ (Supplementary Fig. S7) and PRL+/Ki67+ (data not shown) in the control -/iDTR pituitary which 
did not alter after SOX2+ cell ablation. Moreover, double GH+/PRL+ cells, which would represent intermediate 
stages in transdifferentiation events between both cell types, did not change in Sox2/iDTR pituitary as compared 
to control (Supplementary Fig. S7). On the other hand, enhanced differentiation of the remaining SOX2+ cells 
may play a role in the maintenance of the hormonal cell populations. However, the percentage of SOX2+ cells that 
co-expressed GH (Supplementary Fig. S7) and PRL (data not shown) did not change in adult mice.
The lower ∼30% SOX2+ cell depletion at neonatal age did also not have any impact on the hormonal cell 
populations (Fig. 4b,c), despite the pronounced growth and differentiation process known to occur in the gland 
during the early-postnatal period. However, the proportion of GH+/SOX2+ and PRL+/SOX2+ cells within 
the total AP and within the large group (∼70%) of remaining SOX2+ cells increased after SOX2+ cell ablation 
(Supplementary Fig. S7). This observation, together with the enhanced proliferative activity within the remaining 
SOX2+ cell compartment in the neonatal pituitary (see above), supports the occurrence of an activation response 
of the young SOX2+ stem cells, possibly to sustain the early-postnatal differentiation wave.
Major SOX2+ cell depletion in the adult pituitary does not affect corticotrope expansion upon 
adrenalectomy challenge. The large depletion of SOX2+ stem cells in the adult pituitary did not affect 
the nucleus being labelled with TOPRO3 (blue). Scale bar: 50 μm. Double nSOX2+/Ki67+ cells are indicated 
(arrows). Right: Bar graph showing the proportion of Ki67+/nSOX2+ within the nSOX2+ cell population 
(mean ± SEM; n = 3) in TAM/DT-injected 1-week old Sox2/iDTR mice (light grey) as compared to -/iDTR 
control mice (dark grey), analysed immediately after TAM/DT injection (d9). *p < 0.05.
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Figure 4. SOX2+ cell ablation does not affect pituitary hormonal cell populations. (a) Proportion of hormone+ 
cells as quantified in immunostained AP cell cytospin samples obtained from adult TAM/DT-injected female 
and male control -/iDTR mice (dark grey) and Sox2/iDTR mice (light grey), analysed 1 day (i.e. at d9; left) 
and 6 months (right) later. Bars represent mean ± SEM (females: n = 4 and 3, respectively; males: n = 3). 
No significant differences were observed (see Supplementary Table S1). (b) Proportion of hormone+ cells 
as quantified in immunostained AP cell cytospin samples obtained from 1-week-old TAM/DT-injected 
female and male control -/iDTR mice (dark grey) and Sox2/iDTR mice (light grey), analysed 1 day later (d9). 
Bars represent mean ± SEM (females: n = 3; males: n = 3). No significant differences were observed (see 
Supplementary Table S1). (c) Proportion of hormone+ cells as quantified in immunostained AP cell cytospin 
samples obtained from 1-week-old TAM/DT-injected Sox2/iDTR mice (as compared to control -/iDTR mice, 
set as 100%), analysed 4–6 months later. Bars represent mean ± SEM (from pooled female and male mice: 
n = 3). No significant differences were observed (see Supplementary Table S1). (d) Left: Proportion of cells 
immunoreactive for ACTH and nSOX2 as indicated, quantified in immunostained AP cell cytospin samples 
obtained from adult TAM/DT-injected -/iDTR mice after ADX (black bars), adult TAM/DT-injected Sox2Cre/
iDTR mice after ADX (dark grey bars) and adult TAM/DT-injected Sox2Cre/iDTR mice after SHAM operation 
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hormonal cell proportions in steady-state conditions. To investigate whether SOX2+ cell ablation has an impact 
in more active endocrine cell remodelling conditions of the pituitary, adrenalectomy (ADX) was performed. ADX 
is known to cause a prompt increase (∼20%) in the number of ACTH+ corticotropes in the pituitary, due to the 
disappearance of negative feedback from the target organ10,17. Previous studies provided circumstantial evidence 
that pituitary stem cells may be involved through a mitotic wave followed by differentiation into the new hormo-
nal cells17. A recent study provided more direct evidence using SOX9+ lineage tracing, showing that part (∼20%) 
of the newly formed corticotropes are derived from pituitary (SOX9+) stem cells10. Here, we investigated whether 
the major SOX2+ cell depletion as obtained in adult mice had an effect on the rise of ACTH+ cells after ADX. We 
found that ACTH+ cells increased in number by ∼20% after ADX (as compared to SHAM operation), independ-
ent of prior SOX2+ cell ablation (Fig. 4d). Interestingly, the nSOX2+ cells remaining after DT-mediated depletion 
significantly increased (∼1.5-fold) in number after ADX, indicating that these residual nSOX2+ cells react to the 
ADX-imposed endocrine challenge in the pituitary. In accordance, the proliferating fraction within the remain-
ing nSOX2+ cell population showed an increase by ∼2.5-fold (although not statistically significant; Fig. 4d and 
Supplementary Table S1). Moreover, whereas ADX did not augment the proportion of double nSOX2+/ACTH+ 
cells within the whole nSOX2+ cell population as present in ‘normal’ mice (in comparison with SHAM-operated 
mice), this proportion significantly (2.4-fold) increased within the nSOX2+ cell compartment remaining after 
DT-mediated depletion (Fig. 4d).
Taken together, the large depletion of SOX2+ stem cells in the adult pituitary does not affect hormonal cell 
remodelling upon endocrine challenge, at least as examined for corticotrope expansion after ADX.
Discussion
Stem cells in general play a key role in postnatal homeostatic turnover of their tissue and in repair of injury by 
cell regeneration. However, knowledge on the role of the stem cells in the pituitary gland, as marked by SOX2 
expression, is at present very limited. The pituitary SOX2+ cells appear involved in regeneration after hormonal 
cell-ablation injury6–8, and generate cells of the different hormonal cell lineages during postnatal homeostatic 
turnover, although at low number9,10. We here applied DT-mediated SOX2+ cell ablation to investigate the stem 
cells’ regenerative response and the influence on endocrine cell populations. A previous study examined the 
impact of overall SOX2+ cell ablation in several tissues, but effects in the pituitary were not described4. In this 
particular study, ablation was achieved using the TK/GCV system, signifying that only dividing SOX2+ cells 
were obliterated. Given the low turnover rate of the adult pituitary and the mainly non-proliferative nature of 
its SOX2+ cells2,6,9,10,12, it is highly likely that SOX2+ cells of the gland were not, or not significantly, affected by 
the TK/GCV ablation approach. The DT/iDTR system allows to kill cells through apoptosis independent of cell 
division. In the adult mouse, we obtained a large depletion of pituitary SOX2+ cells, corresponding to a strong 
decrease in stem cell functionality as probed by pituisphere formation. The 80% ablation grade as achieved is 
comparable to transgenic DT-mediated stem cell ablation efficiency realised in other tissues18–20. Surprisingly, 
and counterintuitively for a stem cell population, the remaining SOX2+ cells did not restore the stem cell com-
partment to any extent. Moreover, the large SOX2+ cell depletion did not have any impact on the proportions of 
the hormonal cell populations in the adult gland. So far, no support was found that other mechanisms such as 
higher proliferative activity within the hormonal cell populations and/or transdifferentiation compensate for the 
major absence of SOX2+ cells in the adult gland. Alternatively, other stem cell (sub-)populations in the pituitary 
may take over. Cells expressing the other well-known pituitary stem cell markers SOX9 and E-cadherin were also 
reduced and did not repopulate. Since these markers (as well as Cxadr, also diminished but less pronounced) 
highly co-localize with SOX2 in the pituitary (2,10,12,13), our data do not exclude the existence of (an) additional 
and distinct, yet unidentified stem cell population(s) which naturally contribute(s) to endocrine cell homeostasis, 
or which take(s) over in the absence of the innately homeostatic-driving SOX2+ cells. Contribution of different 
stem cell populations, at least to repair after (stem cell) injury, has been described in other tissues19,21–24. Taken 
together, the bulk of SOX2+ cells do not need to be present to keep hormonal cell populations at normal propor-
tions, suggesting that either the minor remaining fraction of SOX2+ cells is sufficient, or that SOX2+ cells do not 
play a major role in endocrine cell homeostasis in the adult gland. In the mammary gland, LGR6+ stem cells were 
also found to contribute only minimally to adult tissue homeostasis18.
In conditions of more active pituitary remodelling than during steady-state homeostasis, the SOX2+ cells 
remaining after DT-mediated ablation were observed to be activated. First, in the neonatal gland of DT/
TAM-treated pups, proliferating SOX2+ cells were more abundant, and GH- or PRL-coexpressing SOX2+ cells 
increased in number. Both observations suggest that the young pituitary stem cells react to the ‘assault’ in order 
to rescue the early-postnatal maturation and endocrine cell development. In a second pituitary remodelling par-
adigm, the SOX2+ cells remaining after DT-mediated ablation in adult mice reacted to ADX by proliferative 
expansion and increased coexpression of ACTH, thereby supporting their contribution in the ACTH+ cell rise 
after ADX. Thus, the remaining 20% of the SOX2+ cells appear sufficient to sustain the hormonal cell response to 
(light grey bars) (as compared to control -/iDTR mice after SHAM operation, set as 100%). Bars represent 
mean ± SEM (from pooled female and male mice, n = 3–5). *p < 0.05 (see Supplementary Table S1). Right: 
Proportion of cells double-immunoreactive for the factors as indicated, quantified in immunostained AP cell 
cytospin samples obtained from adult TAM/DT-injected -/iDTR mice after ADX (black bars) and adult TAM/
DT-injected Sox2Cre/iDTR mice after ADX (dark grey bars) (as compared to control -/iDTR mice after SHAM 
operation, set as 100%). Double immunostainings were not performed for adult TAM/DT-injected Sox2Cre/
iDTR mice after SHAM operation. Bars represent mean ± SEM (from pooled female and male mice, n = 3–5). 
*p < 0.05 (see Supplementary Table S1).
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the endocrine challenge. If we assume that the remaining fraction is also sufficient for adult homeostatic turnover 
(this fraction at least retains multipotent differentiation capacity in vitro), the following inevitable questions arise: 
why is the SOX2+ cell population so largely redundant and/or what role do the bulk of the SOX2+ cells play? One 
hypothetical explanation is that pituitary function, being critical for the body’s postnatal development and physi-
ology, requires the presence of a sufficient ‘reserve’ of stem cells. On the other hand, the chief role of the pituitary 
SOX2+ stem cells may be situated in other domains such as repair after injury as supported by previous work6–8 
and also found in other tissues (e.g. skin19 and liver25). Further studies are needed to clearly identify their role in 
regeneration after injury, requiring for instance a combined ‘SOX2+ lineage tracing/SOX2+ plus hormone+ cell 
ablation’ model. Alternatively, the cSOX2+ cells which do not express CreERT and thus are not hit by DT, may 
represent the homeostasis-driving population, however implicating that they not only generate new hormonal 
cells but also stem cells (with SOX2 in the nucleus) in order to maintain the stem cell population for homeostasis.
In conclusion, pituitary SOX2+ stem cells do not repopulate after major depletion. Repopulation is not needed 
for hormonal cell homeostasis and remodelling upon endocrine challenge. Answering the question on the key 
role of SOX2+ cells in the adult pituitary requires further studies, including sophisticated transgenic models.
Methods
Transgenic mice. Sox2CreERT2/+ mice (obtained from Dr. Martinez-Barbera, UCL, London) contain a 
CreERT2 expression cassette into the Sox2 locus (knock-in in 1 allele), thus expressing CreERT2 under control 
of the endogenous Sox2 promoter. The CreERT2 is translocated to the nucleus for activity by TAM9. R26iDTR/
iDTR mice harbour the simian DTR gene in the ROSA26 locus preceded by a LoxP-flanked, CRE-excisable STOP 
sequence6–8. Both mouse models were crossed to generate Sox2CreERT2/+;R26iDTR/+ mice. Genotyping was per-
formed as described elsewhere6,9. All animals were kept in the Animal Housing Facility of the KU Leuven expe-
riencing constant humidity, temperature and day/night cycle, and having access to water and food ad libitum. 
Animal experiments were approved by the KU Leuven Ethical Committee. All methods were performed in 
accordance with the relevant guidelines and regulations of the KU Leuven institutional committees.
Treatment of mice for SOX2+ cell ablation. To achieve (maximal) SOX2+ cell ablation in the pitui-
tary gland without evident toxicity, several time and dose injection schedules of TAM (Sigma-Aldrich, Bornem, 
Belgium; dissolved in corn oil) and DT (Sigma-Aldrich; dissolved in PBS) were tested in Sox2CreERT2/+;R26iDTR/+ 
mice (referred to as ‘Sox2/iDTR’) and their respective control Sox2+/+;R26iDTR/+ mice (referred to as ‘-/iDTR’), 
including: 1 TAM injection followed by a 1-day pause before 3 days of DT injection, twice daily; 2 consecutive 
days of TAM injection immediately followed by 3 days of DT treatment; 3 consecutive days of TAM injection 
followed by 2-day pause before 3 or 10 days of DT treatment; and different doses of TAM (0.15 mg and 0.30 mg 
TAM/g body weight). Treatment longer than 3 days with TAM resulted in morbidity most likely due to the large 
amounts of oil injected. Eventually, we identified a schedule of TAM injection for 3 consecutive days (0.15 mg 
TAM/g body weight/day), followed by a 2-day break and then 3 successive days of DT injection (4ng DT/g bod-
yweight, twice a day with 8-hr interval) (see Fig. 1a). No obvious external toxicity was observed in the mice, i.e. 
no hair or prominent weight loss, and no changes in behaviour, posture or gait. Analysis of pituitary glands was 
mainly performed the day immediately after the last DT injection (i.e. d9; see Fig. 1a), or 2, 4 and 6 months later 
(see Fig. 2a), and occasionally at intermediate time points as described. Mice of different ages were treated with 
TAM/DT, i.e. starting at early-postnatal age (1 or 4 weeks of age) or at adult age (8–12 weeks). In each biological 
replicate (indicated by ‘n’), on average 2–4 mice were used per condition. For experiments in which male and 
female mice were pooled, care was taken to have comparable representation of both genders.
Pituisphere assay. The pituitary was isolated from euthanized mice, the AP separated and dispersed into 
single cells using trypsin as previously described26. To generate pituispheres, dissociated AP cells were seeded at a 
density of 100,000 cells/mL in 35-mm non-treated culture dishes (Corning, NY) in serum-free defined medium 
(SFDM; Invitrogen), which was supplemented with B27 (1/50; Life Technologies) and recombinant basic fibro-
blast growth factor (bFGF, 20 ng/mL; R&D Systems, Minneapolis, NE). Pituispheres were counted after 6 days in 
culture (3 dishes per biological replicate, meaning in total 30–90 spheres for Sox2/iDTR AP and 150–350 spheres 
for -/iDTR AP) either immediately fixed with paraformaldehyde (PFA, 4% in PBS; Riedel-de Haën, Seelze, 
Germany) for immunofluorescence (see below), or further analysed for multipotent differentiation capacity as 
described before3,6,8. In short, the clearly rounded spheres were picked manually, transferred to coverslips coated 
with growth factor-reduced Matrigel (1:10; BD Biosciences), and incubated in SFDM without supplements. After 
7 days of culturing, spheres were fixed with PFA (4%).
Immunofluorescence staining. Whole pituitary glands were isolated, fixed with PFA (4%) and embed-
ded in agarose or paraffin as previously described27. For immunofluorescence analysis of agarose-embedded 
pituitaries, coronal vibratome sections (45 μm) were permeabilised with 0.4% Triton X-100 (Sigma-Aldrich) 
and incubated overnight with (a combination of) primary antibodies (see Supplementary Table S2). Next, sec-
tions were incubated with (a combination of) secondary antibodies (see Supplementary Table S2), and nuclei 
were labelled with ToPro3 (Life Technologies), all as described before6–8,16,26,27. Immunofluorescence was 
examined using a Zeiss LSM 510 confocal laser-scanning microscope (Zeiss, Zaventem, Belgium) accessi-
ble through the Cell Imaging Core (CIC; KU Leuven). Z-stacks were collected and analysed using Zeiss LSM 
Image Browser and ImageJ (http://imagej.nih.gov/ij/), and pictures were prepared using the same programs and 
Microsoft PowerPoint (2016). H&E staining was performed on paraffin-embedded pituitary sections (5 μm) as 
described28. The forestomach was isolated, fixed in 10% neutral-buffered formalin and embedded in paraffin. 
Immunofluorescence staining of paraffin-embedded pituitary and forestomach sections was performed after 
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antigen retrieval with citrate buffer (pH 6) and permeabilisation with Triton X-100 (0.1% in PBS). Following 
incubation with primary and secondary antibodies (see Supplementary Table S2), sections were covered with 
Vectashield (containing 4′,6-diamidino-2-phenylindole or DAPI; Vector Laboratories) and analysed with a Leica 
DM5500 epifluorescence microscope (Leica Microsystems, Diegem, Belgium) accessible through InfraMouse 
(KU Leuven-VIB). Recorded images were converted to pictures with ImageJ and Microsoft PowerPoint (2016).
Cytospin samples of 50,000 dissociated AP cells each and pituispheres were fixed with PFA (4%), permeabi-
lised with saponin (0.25%; Sigma-Aldrich), and further immunostained for SOX2, the proliferation marker Ki67 
and/or hormones (see Supplementary Table S2) as described6–8,16,27. Nuclei were visualized using Vectashield 
containing DAPI. To enumerate the respective immunopositive cells, pictures were captured using the Leica 
DM5500 microscope, and cells counted with ImageJ. For the counting of the SOX2+ cells, 3 cytospin slides were 
immunostained per biological replicate, and cells were counted in 10 images per cytospin slide using 40X magni-
fication (in total, 1500–3000 cells were counted per biological replicate). For the counting of the hormone+ cells, 
immunostaining was performed on 2 cytospin slides, and cells were counted in 3–6 images per cytospin slide 
using 20X magnification (in total, 2500–5000 cells were counted per biological replicate). The SOX2+ cell ablation 
grade was calculated using the following formula: % SOX2+ cell ablation = [(average % SOX2+ cells in -/iDTR 
AP – average % SOX2+ cells in Sox2/iDTR AP)/average % SOX2+ cells in -/iDTR AP]*100. Unless otherwise 
stated, data from male and female mice were pooled since no differences were observed in SOX2+ cell ablation.
Adrenalectomy. Adult mice were injected with TAM/DT (see Fig. 1a), and bilateral ADX (-/iDTR: n = 5, 
Sox2/iDTR: n = 4), or SHAM operation (-/iDTR: n = 3, Sox2/iDTR: n = 3) was performed under ketamine/xyla-
zine anaesthesia 4 days later. Mice were given sodium chloride (0.9%) in the drinking water after surgery, and 
pituitaries were harvested for analysis 7 days after surgery.
Gene expression analysis by RT-qPCR. Total RNA was extracted from pituitaries with the RNeasy 
Micro kit (Qiagen), reverse-transcribed using the Superscript III First-Strand Synthesis Supermix (Invitrogen) 
and subjected to SYBR Green-based quantitative real-time PCR (qPCR) using the StepOnePlus Real-Time PCR 
System (AB Applied Biosystems). Forward and reverse primers (see Supplementary Table S3) were designed 
using PerlPrimer29 and PrimerBLAST (https://www.ncbi.nlm.nih.gov/tools/primer-blast/). Glyceraldehyde-
3-phosphate dehydrogenase (Gapdh) and β-actin (ActB) were used as housekeeping genes. Relative gene expres-
sion levels were calculated as ∆Ct values (Ct ‘target’ minus Ct ‘average housekeeping genes’) and compared 
between Sox2/iDTR and -/iDTR to express fold change, i.e. 2−(ΔCt (Sox2/iDTR) − ΔCt (−/iDTR)).
Statistical analysis. Normal distribution was verified with Shapiro-Wilk normality test using GraphPad 
Prism (Version 7.03) before performing statistical analyses. In case of normal distribution, unpaired two-tailed 
t-student test was applied for comparison of 2 groups. When normal distribution was not achieved, Mann–
Whitney U test was applied for comparison of 2 groups. In case of multiple comparisons (more than 2 groups), 
1-way analysis of variance (ANOVA) was performed followed by Tuckey test for Multiple Comparison (data were 
normally distributed). Statistical analyses were performed (in case of n ≥ 3) using GraphPad Prism (Version 7.03) 
and Microsoft Excel software (2016). Statistical significance was defined as p < 0.05. Exact p-values are provided 
in Supplementary Table S1.
References
 1. Vankelecom, H. & Gremeaux, L. Stem cells in the pituitary gland: A burgeoning field. Gen. Comp. Endocrinol. 166, 478–488 (2010).
 2. Fauquier, T., Rizzoti, K., Dattani, M., Lovell-Badge, R. & Robinson, I. C. A. F. SOX2-expressing progenitor cells generate all of the 
major cell types in the adult mouse pituitary gland. Proc. Natl. Acad. Sci. USA 105, 2907–2912 (2008).
 3. Chen, J. et al. Pituitary progenitor cells tracked down by side population dissection. Stem Cells 27, 1182–1195 (2009).
 4. Arnold, K. et al. Sox2(+) adult stem and progenitor cells are important for tissue regeneration and survival of mice. Cell Stem Cell 9, 
317–329 (2011).
 5. Sarkar, A. & Hochedlinger, K. The Sox family of transcription factors : versatile regulators of stem and progenitor cell fate. Stem. Cell 
12, 15–30 (2013).
 6. Fu, Q. & Vankelecom, H. Regenerative capacity of the adult pituitary: multiple mechanisms of lactotrope restoration after transgenic 
ablation. Stem Cells Dev. 21, 3245–3257 (2012).
 7. Fu, Q. et al. The adult pituitary shows stem/progenitor cell activation in response to injury and is capable of regeneration. 
Endocrinology 153, 3224–3235 (2012).
 8. Willems, C. et al. Regeneration in the pituitary after cell-ablation injury: time-related aspects and molecular analysis. Endocrinology 
157, 705–721 (2016).
 9. Andoniadou, C. L. et al. Sox2(+) stem/progenitor cells in the adult mouse pituitary support organ homeostasis and have tumor-
inducing potential. Cell Stem Cell 13, 433–445 (2013).
 10. Rizzoti, K., Akiyama, H. & Lovell-Badge, R. Mobilized adult pituitary stem cells contribute to endocrine regeneration in response to 
physiological demand. Cell Stem Cell 13, 419–432 (2013).
 11. Gaston-Massuet, C. et al. Increased Wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice 
and humans. Proc. Natl. Acad. Sci. USA 108, 11482–11487 (2011).
 12. Garcia-Lavandeira, M. et al. A GRFa2/Prop1/stem (GPS) cell niche in the pituitary. PLoS One 4, e4815 (2009).
 13. Chen, M. et al. Coxsackievirus and adenovirus receptor-positive cells compose the putative stem/progenitor cell niches in the 
marginal cell layer and parenchyma of the rat anterior pituitary. Cell Tissue Res. 354, 823–836 (2013).
 14. Carbajo-Pérez, E. & Watanabe, Y. G. Cellular proliferation in the anterior pituitary of the rat during the postnatal period. Cell Tissue 
Res. 261, 333–338 (1990).
 15. Taniguchi, Y., Yasutaka, S., Kominami, R. & Shinohara, H. Proliferation and differentiation of rat anterior pituitary cells. Anat. 
Embryol. 206, 1–11 (2002).
 16. Gremeaux, L., Fu, Q., Chen, J. & Vankelecom, H. Activated phenotype of the pituitary stem/progenitor cell compartment during the 
early-postnatal maturation phase of the gland. Stem Cells Dev. 21, 801–813 (2012).
 17. Nolan, L. & Levy, A. A population of non-luteinising hormone/non-adrenocorticotrophic hormone-positive cells in the male rat 
anterior pituitary responds mitotically to both gonadectomy and adrenalectomy. J Neuroendocr. 18, 655–661 (2006).
www.nature.com/scientificreports/
1 1SCiEntifiC REPORts | 7: 16940  | DOI:10.1038/s41598-017-16796-2
 18. Blaas, L. et al. Lgr6 labels a rare population of mammary gland progenitor cells that are able to originate luminal mammary tumours. 
Nat. Cell Biol. 18, 1346–1356 (2016).
 19. Hoeck, J. D. et al. Stem cell plasticity enables hair regeneration following Lgr5+ cell loss. Nat. Cell Biol. 19, 666–676 (2017).
 20. Zhang, Y. et al. Hypothalamic stem cells control ageing speed partly through exosomal miRNAs. Nature 548, 52–57 (2017).
 21. Tian, H. et al. A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature 478, 255–259 (2011).
 22. Yan, K., Chia, L. & Li, X. The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations. Pnas 109, 
466–471 (2012).
 23. Vallone, V. F. et al. Trop2 marks transient gastric fetal epithelium and adult regenerating cells after epithelial damage. Development 
143, 1452–1463 (2016).
 24. Ito, M. et al. Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis. Nat. Med. 11, 
1351–1354 (2005).
 25. Huch, M. et al. In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration. Nature 494, 247–250 (2013).
 26. Chen, J. et al. The adult pituitary contains a cell population displaying stem/progenitor cell and early embryonic characteristics. 
Endocrinology 146, 3985–3998 (2005).
 27. Mertens, F. et al. Pituitary tumors contain a side population with tumor stem cell-associated characteristics. Endocr. Relat. Cancer 
22, 481–504 (2015).
 28. Boretto, M. et al. Development of organoids from mouse and human endometrium showing endometrial epithelium physiology and 
long-term expandability. Development 144, 1775–1786 (2017).
 29. Marshall, O. J. PerlPrimer: Cross-platform, graphical primer design for standard, bisulphite and real-time PCR. Bioinformatics 20, 
2471–2472 (2004).
Acknowledgements
We thank Yvonne Van Goethem and Master students for their experimental and technical help. We are very 
grateful to Prof. C. Mathieu and Jos Laureys (Department of Chronic Diseases, Metabolism and Ageing, Clinical 
and Experimental Endocrinology, KU Leuven) for their expert assistance in the adrenalectomy procedures. We 
are also grateful to InfraMouse (KU Leuven-VIB, Hercules type 3 project ZW09-03) and the Cell Imaging Core 
(CIC; KU Leuven) for the use of their histological instruments and microscopes. This work was supported by 
grants from the KU Leuven (Research Fund; GOA) and from the Fund for Scientific Research (FWO) - Flanders 
(Belgium). H.R. is supported by a PhD Fellowship from the IWT (Agency for Innovation by Science and 
Technology; Flanders, Belgium). B.C. and A.V. are supported by a PhD Fellowship from the FWO, and M.B. is a 
PhD Fellow supported by a GOA grant.
Author Contributions
H.R. designed the concepts and experiments, performed the experiments and the data analysis, interpreted 
the results and co-wrote the manuscript; B.C. helped in a number of experiments, in data interpretation and in 
animal husbandry; M.B. provided information and help in setting up some staining experiments; C.G. set up and 
performed adrenalectomy experiments; A.V. helped in a number of experiments and in animal husbandry; H.V. 
designed and supervised the project, co-developed the concepts and ideas, co-designed the experiments, helped 
to analyse and interpret the data and wrote the manuscript. All authors reviewed the manuscript.
Additional Information
Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-017-16796-2.
Competing Interests: The authors declare that they have no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2017
